Works about TRASTUZUMAB

Results: 2883

Presentation and management of female breast cancer in Egypt.
Published in:
Eastern Mediterranean Health Journal, 2022, v. 28, n. 10, p. 725, doi. 10.26719/emhj.22.076
By:
- Rostom, Yousri;
- Abdelmoneim, Salah-Eldin;
- Shaker, Marwa;
- Mahmoud, Nayera
Publication type:
Article
Breast cancer overview: Current treatments.
Published in:
Practice Nursing, 2009, v. 20, n. 6, p. 282, doi. 10.12968/pnur.2009.20.6.42553
By:
- Blowers, Elaine;
- Foy, Sharon
Publication type:
Article
Breast cancer patients should not live without a HER-2/neu tissue result -- But how safe can they live with it?
Published in:
Wiener Klinische Wochenschrift, 2004, v. 116, n. 1/2, p. 3, doi. 10.1007/BF03040416
By:
- Lüftner, Diana
Publication type:
Article
Radiolabelled <sup>177</sup>Lu‐Bispidine‐Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancers.
Published in:
Chemistry - A European Journal, 2024, v. 30, n. 14, p. 1, doi. 10.1002/chem.202303805
By:
- Cieslik, Patrick A.;
- Klingler, Simon;
- Nolff, Mirja;
- Holland, Jason P.
Publication type:
Article
Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting.
Published in:
Chemistry - A European Journal, 2023, v. 29, n. 11, p. 1, doi. 10.1002/chem.202202491
By:
- Hashad, Rania A.;
- Jap, Edwina;
- Casey, Joanne L.;
- Candace Ho, Y. T.;
- Wright, Alexander;
- Thalmann, Claudia;
- Sleeman, Mark;
- Lupton, David W.;
- Hagemeyer, Christoph E.;
- Cryle, Max J.;
- Robert, Remy;
- Alt, Karen
Publication type:
Article
A Traceless Site‐Specific Conjugation on Native Antibodies Enables Efficient One‐Step Payload Assembly.
Published in:
Angewandte Chemie, 2022, v. 134, n. 36, p. 1, doi. 10.1002/ange.202204132
By:
- Zeng, Yue;
- Shi, Wei;
- Dong, Qian;
- Li, Wanzhen;
- Zhang, Jianxin;
- Ren, Xuelian;
- Tang, Caihong;
- Liu, Bo;
- Song, Yuanli;
- Wu, Yali;
- Diao, Xingxing;
- Zhou, Hu;
- Huang, He;
- Tang, Feng;
- Huang, Wei
Publication type:
Article
Ethynylation of Cysteine Residues: From Peptides to Proteins in Vitro and in Living Cells.
Published in:
Angewandte Chemie, 2020, v. 132, n. 27, p. 11054, doi. 10.1002/ange.202002626
By:
- Tessier, Romain;
- Nandi, Raj Kumar;
- Dwyer, Brendan G.;
- Abegg, Daniel;
- Sornay, Charlotte;
- Ceballos, Javier;
- Erb, Stéphane;
- Cianférani, Sarah;
- Wagner, Alain;
- Chaubet, Guilhem;
- Adibekian, Alexander;
- Waser, Jerome
Publication type:
Article
Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry.
Published in:
Biopharmaceutics & Drug Disposition, 2023, v. 44, n. 5, p. 380, doi. 10.1002/bdd.2371
By:
- Habara, Hiromi;
- Okamoto, Hiromi;
- Nagai, Yoko;
- Oitate, Masataka;
- Takakusa, Hideo;
- Watanabe, Nobuaki
Publication type:
Article
Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells.
Published in:
Histochemistry & Cell Biology, 2020, v. 153, n. 5, p. 367, doi. 10.1007/s00418-020-01857-x
By:
- Böckelmann, Lukas;
- Starzonek, Christin;
- Niehoff, Ann-Christin;
- Karst, Uwe;
- Thomale, Jürgen;
- Schlüter, Hartmut;
- Bokemeyer, Carsten;
- Aigner, Achim;
- Schumacher, Udo
Publication type:
Article
Pan-immune-inflammation Value in Metastatic HER2-Positive Breast Cancer Patients.
Published in:
Eurasian Journal of Medical Investigation, 2023, v. 7, n. 3, p. 209, doi. 10.14744/ejmi.2023.18471
By:
- Gulmez, Ahmet;
- Harputluoglu, Hakan
Publication type:
Article
Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data.
Published in:
Eurasian Journal of Medical Investigation, 2023, v. 7, n. 2, p. 153, doi. 10.14744/ejmi.2023.22720
By:
- Topcu, Atakan;
- Besiroglu, Mehmet;
- Atci, Muhammed Mustafa;
- Secmeler, Saban;
- Ayhan, Murat;
- Ozkan, Metin;
- Bozkurt, Oktay;
- Urakci, Zuhat;
- Ay, Seval;
- Geredeli, Caglayan;
- Yasin, Ayse Irem;
- Pasin, Ozge;
- Turk, Haci Mehmet
Publication type:
Article
Importance of Prognostic Nutritional Index in Patients with Metastatic Breast Cancer Treated with Trastuzumab Emtansine.
Published in:
Eurasian Journal of Medical Investigation, 2022, v. 6, n. 4, p. 484, doi. 10.14744/ejmi.2022.90000
By:
- Koseci, Tolga;
- Bulut, Gulcan;
- Ata, Serdar;
- Bayram, Ertugrul;
- Cil, Timucin;
- Eser, Kadir
Publication type:
Article
Effect of Inflammatory Markers on the Pathologic Complete Response in the Neoadjuvan Treatment of HER-2 Positive Local Advanced Breast Cancer.
Published in:
Eurasian Journal of Medical Investigation, 2022, v. 6, n. 4, p. 417, doi. 10.14744/ejmi.2022.65683
By:
- Gulmez, Ahmet;
- Harputluoglu, Hakan
Publication type:
Article
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: Long-term survival analysis of the DESTINY-Breast03 trial.
Published in:
Breast Cancer Research Review, 2024, n. 45, p. 4
By:
- Okonji, David
Publication type:
Article
Long-term outcomes of adjuvant trastuzumab for 9 weeks or 1 year for ERBB2-positive breast cancer: A secondary analysis of the SOLD randomized clinical trial.
Published in:
Breast Cancer Research Review, 2024, n. 45, p. 4
By:
- Okonji, David
Publication type:
Article
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases.
Published in:
Breast Cancer Research Review, 2023, n. 40, p. 5
By:
- R., Bartsch
Publication type:
Article
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA).
Published in:
Breast Cancer Research Review, 2023, n. 40, p. 4
By:
- J., Wu
Publication type:
Article
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03.
Published in:
Breast Cancer Research Review, 2023, n. 40, p. 4
By:
- S. A., Hurvitz
Publication type:
Article
Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer.
Published in:
Breast Cancer Research Review, 2022, n. 38, p. 5
By:
- S., Modi
Publication type:
Article
Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer.
Published in:
Breast Cancer Research Review, 2022, n. 37, p. 4
By:
- J., Cortés
Publication type:
Article
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial.
Published in:
Breast Cancer Research Review, 2021, n. 34, p. 5
By:
- Okonji, David
Publication type:
Article
In Silico Design and Evaluation of scFv-CdtB as a Novel Immunotoxin for Breast Cancer Treatment.
Published in:
International Journal of Cancer Management, 2020, v. 13, n. 1, p. 1, doi. 10.5812/ijcm.96094
By:
- Vafadar, Asma;
- Taheri-Anganeh, Mortaza;
- Movahedpour, Ahmad;
- Jamali, Zeinab;
- Irajie, Cambyz;
- Ghasemi, Younes;
- Savardashtaki, Amir
Publication type:
Article
In Silico Evaluation of Two Targeted Chimeric Proteins Based on Bacterial Toxins for Breast Cancer Therapy.
Published in:
International Journal of Cancer Management, 2019, v. 12, n. 2, p. 1, doi. 10.5812/ijcm.83315
By:
- Goleij, Zoleikha;
- Hosseini, HamidehMahmoodzadeh;
- Amin, Mohsen;
- Amani, Jafar;
- Behzadi, Elham;
- Fooladi, Abbas Ali Imani
Publication type:
Article
Immunogenicity of Rituximab, Trastuzumab, and Bevacizumab Monoclonal Antibodies in Patients with Malignant Diseases.
Published in:
International Journal of Cancer Management, 2018, v. 11, n. 11, p. 1, doi. 10.5812/ijcm.64983
By:
- Saffari, Fatemeh;
- Jafarzadeh, Abdollah;
- Khandani, Behjat Kalantari;
- Saffari, Farzaneh;
- Soleimanyamoli, Saeed;
- Mohammadi, Mohammadmahdi
Publication type:
Article
The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study.
Published in:
2016
By:
- Goldhar, Hart A.;
- Yan, Andrew T.;
- Ko, Dennis T.;
- Earle, Craig C.;
- Tomlinson, George A.;
- Trudeau, Maureen E.;
- Krahn, Murray D.;
- Krzyzanowska, Monika K.;
- Pal, Raveen S.;
- Brezden-Masley, Christine;
- Gavura, Scott;
- Lien, Kelly;
- Chan, Kelvin K. W.
Publication type:
journal article
Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv136
By:
- Carvajal-Hausdorf, Daniel E.;
- Schalper, Kurt A.;
- Pusztai, Lajos;
- Psyrri, Amanda;
- Kalogeras, Konstantine T.;
- Kotoula, Vasiliki;
- Fountzilas, George;
- Rimm, David L.
Publication type:
Article
Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv136
By:
- Carvajal-Hausdorf, Daniel E.;
- Schalper, Kurt A.;
- Pusztai, Lajos;
- Psyrri, Amanda;
- Kalogeras, Konstantine T.;
- Kotoula, Vasiliki;
- Fountzilas, George;
- Rimm, David L.
Publication type:
Article
Effect of p95HER2/611CTF on the Response toTrastuzumab and Chemotherapy.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 11, p. 1, doi. 10.1093/jnci/dju291
By:
- Parra-Palau, Josep Lluís;
- Morancho, Beatriz;
- Peg, Vicente;
- Escorihuela, Marta;
- Scaltriti, Maurizio;
- Vicario, Rocio;
- Zacarias-Fluck, Mariano;
- Pedersen, Kim;
- Pandiella, Atanasio;
- Nuciforo, Paolo;
- Serra, Violeta;
- Cortes, Javier;
- Baselga, José;
- Perou, Charles M.;
- Prat, Aleix;
- Rubio, Isabel T.;
- Arribas, Joaquín
Publication type:
Article
Comparative Effectiveness of Neoadjuvant Therapy for HER2–Positive Breast Cancer: A Network Meta-Analysis.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 9, p. 1, doi. 10.1093/jnci/dju203
By:
- Nagayama, Aiko;
- Hayashida, Tetsu;
- Jinno, Hiromitsu;
- Takahashi, Maiko;
- Seki, Tomoko;
- Matsumoto, Akiko;
- Murata, Takeshi;
- Ashrafian, Hutan;
- Athanasiou, Thanos;
- Okabayashi, Koji;
- Kitagawa, Yuko
Publication type:
Article
Making Sense of Dual HER2-Targeting in Early Breast Cancer?
Published in:
2014
By:
- Carey, Lisa A.;
- Barry, William
Publication type:
Editorial
Therapeutic Targeting of Integrin αvβ6 in Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 8, p. 1, doi. 10.1093/jnci/dju169
By:
- Moore, Kate M.;
- Thomas, Gareth J.;
- Duffy, Stephen W.;
- Warwick, Jane;
- Gabe, Rhian;
- Chou, Patrick;
- Ellis, Ian O.;
- Green, Andrew R.;
- Haider, Syed;
- Brouilette, Kellie;
- Saha, Antonio;
- Vallath, Sabari;
- Bowen, Rebecca;
- Chelala, Claude;
- Eccles, Diana;
- Tapper, William J.;
- Thompson, Alastair M.;
- Quinlan, Phillip;
- Jordan, Lee;
- Gillett, Cheryl
Publication type:
Article
Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31.
Published in:
JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 23, p. 1782, doi. 10.1093/jnci/djt321
By:
- Pogue-Geile, Katherine L.;
- Kim, Chungyeul;
- Jeong, Jong-Hyeon;
- Tanaka, Noriko;
- Bandos, Hanna;
- Gavin, Patrick G.;
- Fumagalli, Debora;
- Goldstein, Lynn C.;
- Sneige, Nour;
- Burandt, Eike;
- Taniyama, Yusuke;
- Bohn, Olga L.;
- Lee, Ahwon;
- Kim, Seung-Il;
- Reilly, Megan L.;
- Remillard, Matthew Y.;
- Blackmon, Nicole L.;
- Kim, Seong-Rim;
- Horne, Zachary D.;
- Rastogi, Priya
Publication type:
Article
Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 13, p. 960, doi. 10.1093/jnci/djt121
By:
- Loi, Sherene;
- Michiels, Stefan;
- Lambrechts, Diether;
- Fumagalli, Debora;
- Claes, Bart;
- Kellokumpu-Lehtinen, Pirkko-Liisa;
- Bono, Petri;
- Kataja, Vesa;
- Piccart, Martine J.;
- Joensuu, Heikki;
- Sotiriou, Christos
Publication type:
Article
Cardiotoxicity Debated for Anthracyclines and Trastuzumab in Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 12, p. 835, doi. 10.1093/jnci/djt161
By:
- Brower, Vicki
Publication type:
Article
HER2-Directed T-Cell Receptor–Mimicking Antibody: A “Me Too” or an Example of Novel Antitumor Aggressive Mimicry?
Published in:
JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 3, p. 161, doi. 10.1093/jnci/djs636
By:
- Bianchini, Giampaolo;
- Gianni, Luca
Publication type:
Article
Antitumor Activity of a Monoclonal Antibody Targeting Major Histocompatibility Complex Class I–Her2 Peptide Complexes.
Published in:
JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 3, p. 202, doi. 10.1093/jnci/djs521
By:
- Jain, Rinki;
- Rawat, Amit;
- Verma, Bhavna;
- Markiewski, Maciej M.;
- Weidanz, Jon A.
Publication type:
Article
PDQ (Physician Data Query).
Published in:
JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 17, p. 1278, doi. 10.1093/jnci/djs390
Publication type:
Article
Risk of Heart Failure in Breast Cancer Patients After Anthracycline andTrastuzumabTreatment: A Retrospective Cohort Study.
Published in:
JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 17, p. 1293, doi. 10.1093/jnci/djs317
By:
- Aiello Bowles, Erin J.;
- Wellman, Robert;
- Spencer Feigelson, Heather;
- Onitilo, Adedayo A.;
- Freedman, Andrew N.;
- Delate, Thomas;
- Allen, Larry A.;
- Nekhlyudov, Larissa;
- B. Goddard, Katrina A.;
- Davis, Robert L.;
- Habel, Laurel A.;
- Ulcickas Yood, Marianne;
- McCarty, Cathine;
- Magid, David J.;
- Wagner, Edward H.
Publication type:
Article
Trastuzumab and Congestive Heart Failure: What Can We Learn From Use in the Community?
Published in:
2012
By:
- Geiger, Ann M.
Publication type:
Editorial
Cancer Stem Cell Hypothesis and Trastuzumab in HER2-Negative Tumors.
Published in:
JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 13, p. 968, doi. 10.1093/jnci/djs307
By:
- Tuma, Rabiya S.
Publication type:
Article
Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria.
Published in:
JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 159, doi. 10.1093/jnci/djr490
By:
- Perez, Edith A.;
- Dueck, Amylou C.;
- McCullough, Ann E.;
- Reinholz, Monica M.;
- Tenner, Kathleen S.;
- Davidson, Nancy E.;
- Gralow, Julie;
- Harris, Lyndsay N.;
- Kutteh, Leila A.;
- Hillman, David W.;
- Jenkins, Robert B.;
- Chen, Beiyun
Publication type:
Article
Hints of Future Progress for HER-2 Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 7, p. 535, doi. 10.1093/jnci/djr122
By:
- Twombly, Renee
Publication type:
Article
Gastric Cancer: Trastuzumab Trial Results Spur Search for Other Targets.
Published in:
JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 19, p. 1306, doi. 10.1093/jnci/djp341
By:
- Hede, Karyn
Publication type:
Article
Trastuzumab Before Breast Surgery? Large Trial Says Yes But Does Not Quell Debate.
Published in:
JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 7, p. 448, doi. 10.1093/jnci/djp072
By:
- Rowan, Karen
Publication type:
Article
Trial Offers Early Test Case for Personalized Medicine.
Published in:
JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 3, p. 136, doi. 10.1093/jncI/djn506
By:
- Garber, Ken
Publication type:
Article
Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain.
Published in:
JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 15, p. 1092, doi. 10.1093/jnci/djn216
By:
- Gril, Brunilde;
- Palmieri, Diane;
- Bronder, Julie L.;
- Herring, Jeanne M.;
- Vega-Valle, Eleazar;
- Feigenbaum, Lionel;
- Liewehr, David J.;
- Steinberg, Seth M.;
- Merino, Maria J.;
- Rubin, Stephen D.;
- Steeg, Patricia S.
Publication type:
Article
Inconsistency of HER2 Test Raises Questions.
Published in:
JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 14, p. 1064, doi. 10.1093/jnci/djm075
By:
- Tuma, Rabiya S.
Publication type:
Article
Trastuzumab Faces Trials, Clinical and Otherwise.
Published in:
JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 5, p. 296, doi. 10.1093/jnci/djj110
By:
- Tuma, Rabiya S.
Publication type:
Article
Oh, Canada: Public Outcry Pushed Demand for Trastuzumab for Early-Stage Breast Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 18, p. 1327, doi. 10.1093/jnci/dji327
By:
- Smith, Michael
Publication type:
Article
Trastuzumab Trials Steal Show at ASCO Meeting.
Published in:
JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 12, p. 870, doi. 10.1093/jnci/97.12.870
By:
- Tuma, Rabiya S.
Publication type:
Article